PMC:7534795 / 120482-120945 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T666","span":{"begin":1,"end":9},"obj":"Disease"},{"id":"T667","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"T668","span":{"begin":358,"end":366},"obj":"Disease"}],"attributes":[{"id":"A666","pred":"mondo_id","subj":"T666","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A667","pred":"mondo_id","subj":"T667","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A668","pred":"mondo_id","subj":"T668","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" COVID-19. More research is undoubtedly needed before definitive recommendations about the routine use of n-3 PUFAs in the context of COVID-19 can be made particularly that dosing data and pharmacokinetics studies of both enteral and parenteral n-3 PUFAs in critically ill patients are highly variable and incomplete.\n\n10 Summary and conclusion\nIn summary, COVID-19 is rapidly spreading around the globe and our understanding of the virus is limited. To date, th"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T212","span":{"begin":434,"end":439},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":" COVID-19. More research is undoubtedly needed before definitive recommendations about the routine use of n-3 PUFAs in the context of COVID-19 can be made particularly that dosing data and pharmacokinetics studies of both enteral and parenteral n-3 PUFAs in critically ill patients are highly variable and incomplete.\n\n10 Summary and conclusion\nIn summary, COVID-19 is rapidly spreading around the globe and our understanding of the virus is limited. To date, th"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T82196","span":{"begin":110,"end":115},"obj":"Chemical"},{"id":"T30589","span":{"begin":249,"end":254},"obj":"Chemical"}],"attributes":[{"id":"A73787","pred":"chebi_id","subj":"T82196","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A94683","pred":"chebi_id","subj":"T30589","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":" COVID-19. More research is undoubtedly needed before definitive recommendations about the routine use of n-3 PUFAs in the context of COVID-19 can be made particularly that dosing data and pharmacokinetics studies of both enteral and parenteral n-3 PUFAs in critically ill patients are highly variable and incomplete.\n\n10 Summary and conclusion\nIn summary, COVID-19 is rapidly spreading around the globe and our understanding of the virus is limited. To date, th"}

{"project":"LitCovid-sentences","denotations":[{"id":"T728","span":{"begin":11,"end":317},"obj":"Sentence"},{"id":"T729","span":{"begin":319,"end":345},"obj":"Sentence"},{"id":"T730","span":{"begin":346,"end":451},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" COVID-19. More research is undoubtedly needed before definitive recommendations about the routine use of n-3 PUFAs in the context of COVID-19 can be made particularly that dosing data and pharmacokinetics studies of both enteral and parenteral n-3 PUFAs in critically ill patients are highly variable and incomplete.\n\n10 Summary and conclusion\nIn summary, COVID-19 is rapidly spreading around the globe and our understanding of the virus is limited. To date, th"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3444","span":{"begin":273,"end":281},"obj":"Species"},{"id":"3449","span":{"begin":106,"end":115},"obj":"Chemical"},{"id":"3450","span":{"begin":245,"end":254},"obj":"Chemical"},{"id":"3453","span":{"begin":1,"end":9},"obj":"Disease"},{"id":"3454","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"3455","span":{"begin":258,"end":272},"obj":"Disease"},{"id":"3480","span":{"begin":358,"end":366},"obj":"Disease"}],"attributes":[{"id":"A3444","pred":"tao:has_database_id","subj":"3444","obj":"Tax:9606"},{"id":"A3449","pred":"tao:has_database_id","subj":"3449","obj":"MESH:D015525"},{"id":"A3450","pred":"tao:has_database_id","subj":"3450","obj":"MESH:D015525"},{"id":"A3453","pred":"tao:has_database_id","subj":"3453","obj":"MESH:C000657245"},{"id":"A3454","pred":"tao:has_database_id","subj":"3454","obj":"MESH:C000657245"},{"id":"A3455","pred":"tao:has_database_id","subj":"3455","obj":"MESH:D016638"},{"id":"A3480","pred":"tao:has_database_id","subj":"3480","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" COVID-19. More research is undoubtedly needed before definitive recommendations about the routine use of n-3 PUFAs in the context of COVID-19 can be made particularly that dosing data and pharmacokinetics studies of both enteral and parenteral n-3 PUFAs in critically ill patients are highly variable and incomplete.\n\n10 Summary and conclusion\nIn summary, COVID-19 is rapidly spreading around the globe and our understanding of the virus is limited. To date, th"}